Eupraxia Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Eupraxia Pharmaceuticals Inc
TickerEPRX
CIK #0001581178
CUSIP29842P105
SectorLife Sciences - Pharmaceutical Preparations
Address201-2067 Cadboro Bay Rd, Victoria, BC V8R 5G4
Source [EDGAR]
CIK Filing 2011 - 2026
[0001581178] 6-K
[0001581178] D
[0001581178] SC 13D
[0001581178] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Disbrow Robert Eupraxia Pharmaceuticals Inc [2024-11-14] 8.6
Freedman Joseph S Eupraxia Pharmaceuticals Inc [2024-11-07] 12.4
Form 13F Holdings
Firm Period DFND Voting Shares
Scotia Capital Inc [2025-06-30] DFND 0 1,291,989
Royal Bank of Canada [2025-06-30] DFND 292,384 428,584
Goldman Sachs Group Inc [2025-06-30] DFND 39,800 39,800
UBS Group AG [2025-06-30] DFND 0 37,499
Bank of Montreal /Can/ [2025-06-30] DFND 37,250 37,250
Ingalls & Snyder LLC [2025-06-30] OTR 0 37,200
JPMorgan Chase & Co [2025-06-30] DFND 18,717 18,717
Citadel Advisors LLC [2025-06-30] DFND 18,236 18,236
CIBC World Market Inc [2025-06-30] SOLE 15,000 15,000
Bank of America Corp /DE/ [2025-06-30] DFND 12,300 12,559
Raymond James Financial Inc [2025-06-30] DFND 0 12,212
Quadrature Capital Ltd [2025-06-30] OTR 0 10,700
TD Waterhouse Canada Inc. [2025-06-30] DFND 9,600 9,600
National Bank of Canada /FI/ [2025-06-30] DFND 0 730
Concourse Financial Group Securities Inc [2025-06-30] SOLE 0 0
Prev | Page 3 | Next
Terms | Privacy | Providers | Guide
tony@aum13f.com